Yung Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yung Hwang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Merav Socolovsky
Affiliation Department of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, Massachusetts, United States of America
3 shared publications - Daniel Hidalgo
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, USA
2 shared publications - Aishwarya Swaminathan
Department of Molecular, Cell and Cancer Biology, UMass Chan Medical School
1 shared publication - Allon Moshe Klein
Department of Systems Biology, Harvard Medical School, Boston, USA
1 shared publication - Anna E. Eastman
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, USA
1 shared publication Ashley Winward
Department of Molecular, Cell and Cancer Biology, UMass Chan Medical School
1 shared publication
Latest Publications
- Open Access
IL-17A primes an early progenitor compartment to tune the erythropoietic feedback circuit
Feedback control of erythropoiesis exemplifies conflicting goals in tissue homeostasis: maintaining fast reactivity to stress while minimizing proliferative burden on progenitors in the steady state. Here we show that these conflicting goals are tuned through the combinatorial action of cytokines. We find that IL-17A, a pro-inflammatory cytokine, mediates striking synergism with the negative feedback signal erythropoietin (Epo) in vivo, accelerating the erythropoietic response to hypoxia. A model of erythropoietic control shows increased reactivity may occur through two cell circuit designs, with one having far lower constitutive progenitor burden in normoxia. IL-17A acts through this optimal design by sensitizing progenitors to Epo, a model supported by multiple experimental observations. We suggest that IL-17A signals impending hypoxia during infections, tuning erythropoiesis in favor of a faster stress response. Our study highlights IL-17A as a potential erythropoietic therapeutic agent and serves as a model of homeostatic tuning in stem and progenitor cell circuits.
Open AccessIL-17A primes an early progenitor compartment to tune the erythropoietic feedback circuit
Feedback control of erythropoiesis exemplifies conflicting goals in tissue homeostasis: maintaining fast reactivity to stress while minimizing proliferative burden on progenitors in the steady state. Here we show that these conflicting goals are tuned through the combinatorial action of cytokines. We find that IL-17A, a pro-inflammatory cytokine, mediates striking synergism with the negative feedback signal erythropoietin (Epo) in vivo, accelerating the erythropoietic response to hypoxia. A model of erythropoietic control shows increased reactivity may occur through two cell circuit designs, with one having far lower constitutive progenitor burden in normoxia. IL-17A acts through this optimal design by sensitizing progenitors to Epo, a model supported by multiple experimental observations. We suggest that IL-17A signals impending hypoxia during infections, tuning erythropoiesis in favor of a faster stress response. Our study highlights IL-17A as a potential erythropoietic therapeutic agent and serves as a model of homeostatic tuning in stem and progenitor cell circuits.
- Open Access
- 17 December 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
The erythroid terminal differentiation program couples sequential cell divisions with progressive reductions in cell size. The erythropoietin receptor (EpoR) is essential for erythroblast survival, but its other functions are not well characterized. Here we use Epor−/− mouse erythroblasts endowed with survival signaling to identify novel non-redundant EpoR functions. We find that, paradoxically, EpoR signaling increases red cell size while also increasing the number and speed of erythroblast cell cycles. EpoR-regulation of cell size is independent of established red cell size regulation by iron. High erythropoietin (Epo) increases red cell size in wild-type mice and in human volunteers. The increase in mean corpuscular volume (MCV) outlasts the duration of Epo treatment and is not the result of increased reticulocyte number. Our work shows that EpoR signaling alters the relationship between cycling and cell size. Further, diagnostic interpretations of increased MCV should now include high Epo levels and hypoxic stress.
- 17 December 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
Open AccessEpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
The erythroid terminal differentiation program couples sequential cell divisions with progressive reductions in cell size. The erythropoietin receptor (EpoR) is essential for erythroblast survival, but its other functions are not well characterized. Here we use Epor−/− mouse erythroblasts endowed with survival signaling to identify novel non-redundant EpoR functions. We find that, paradoxically, EpoR signaling increases red cell size while also increasing the number and speed of erythroblast cell cycles. EpoR-regulation of cell size is independent of established red cell size regulation by iron. High erythropoietin (Epo) increases red cell size in wild-type mice and in human volunteers. The increase in mean corpuscular volume (MCV) outlasts the duration of Epo treatment and is not the result of increased reticulocyte number. Our work shows that EpoR signaling alters the relationship between cycling and cell size. Further, diagnostic interpretations of increased MCV should now include high Epo levels and hypoxic stress.
- 11 September 2020
- Published by Wiley in WIREs Mechanisms of Disease
- Vol. 13 (2) , e1504
The shifting shape and functional specializations of the cell cycle during lineage development
Essentially all cell cycling in multicellular organisms in vivo takes place in the context of lineage differentiation. This notwithstanding, the regulation of the cell cycle is often assumed to be generic, independent of tissue or developmental stage. Here we review developmental‐stage‐specific cell cycle adaptations that may influence developmental decisions, in mammalian erythropoiesis and in other lineages. The length of the cell cycle influences the balance between self‐renewal and differentiation in multiple tissues, and may determine lineage fate. Shorter cycles contribute to the efficiency of reprogramming somatic cells into induced pluripotency stem cells and help maintain the pluripotent state. While the plasticity of G1 length is well established, the speed of S phase is emerging as a novel regulated parameter that may influence cell fate transitions in the erythroid lineage, in neural tissue and in embryonic stem cells. A slow S phase may stabilize the self‐renewal state, whereas S phase shortening may favor a cell fate change. In the erythroid lineage, functional approaches and single‐cell RNA‐sequencing show that a key transcriptional switch, at the transition from self‐renewal to differentiation, is synchronized with and dependent on S phase. This specific S phase is shorter, as a result of a genome‐wide increase in the speed of replication forks. Furthermore, there is progressive shortening in G1 in the period preceding this switch. Together these studies suggest an integrated regulatory landscape of the cycle and differentiation programs, where cell cycle adaptations are controlled by, and in turn feed back on, the propagation of developmental trajectories.This article is categorized under: Congenital Diseases > Stem Cells and Development
- 11 September 2020
- Published by Wiley in WIREs Mechanisms of Disease
- Vol. 13 (2) , e1504
The shifting shape and functional specializations of the cell cycle during lineage development
Essentially all cell cycling in multicellular organisms in vivo takes place in the context of lineage differentiation. This notwithstanding, the regulation of the cell cycle is often assumed to be generic, independent of tissue or developmental stage. Here we review developmental‐stage‐specific cell cycle adaptations that may influence developmental decisions, in mammalian erythropoiesis and in other lineages. The length of the cell cycle influences the balance between self‐renewal and differentiation in multiple tissues, and may determine lineage fate. Shorter cycles contribute to the efficiency of reprogramming somatic cells into induced pluripotency stem cells and help maintain the pluripotent state. While the plasticity of G1 length is well established, the speed of S phase is emerging as a novel regulated parameter that may influence cell fate transitions in the erythroid lineage, in neural tissue and in embryonic stem cells. A slow S phase may stabilize the self‐renewal state, whereas S phase shortening may favor a cell fate change. In the erythroid lineage, functional approaches and single‐cell RNA‐sequencing show that a key transcriptional switch, at the transition from self‐renewal to differentiation, is synchronized with and dependent on S phase. This specific S phase is shorter, as a result of a genome‐wide increase in the speed of replication forks. Furthermore, there is progressive shortening in G1 in the period preceding this switch. Together these studies suggest an integrated regulatory landscape of the cycle and differentiation programs, where cell cycle adaptations are controlled by, and in turn feed back on, the propagation of developmental trajectories.This article is categorized under: Congenital Diseases > Stem Cells and Development